𝔖 Bobbio Scriptorium

✦ LIBER ✦

Asthma control with fluticasone propionate/salmeterol 100/50$mu;g DiskusS versus montelukast in patients previously receiving short-acting beta2-agonists*1

✍ Scribed by CALHOUN, W

Book ID: 119273672
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 26 KB
Volume: 113
Category: Article
ISSN: 1097-6825
DOI: 10.1016/j.jaci.2003.12.411

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Loss of asthma control when patients rec

Loss of asthma control when patients receiving fluticasone propionate/salmeterol 100/50$mu;g DiskusS are ?stepped-down? to fluticasone propionate, salmeterol or montelukast alone*1

✍ KEONIG, S 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 26 KB

In patients taking fluticasone propionat

In patients taking fluticasone propionate/salmeterol 100/50$mu;g DiskusS for asthma, fluticasone propionate nasal spray 200$mu;g QD is superior to montelukast 10mg QD in the treatment of allergic rhinitis in patients with coexistent allergic rhinitis*1Implication for the one airway hypothesis

✍ NELSON, H 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 26 KB

In patients taking fluticasone propionat

In patients taking fluticasone propionate/salmeterol 100/50$mu;g DiskusS for asthma, the addition of fluticasone propionate nasal spray 200$mu;g QD to treat concomitant allergic rhinitis has a safety profile comparable to the addition of montelukast 10mg QD or placebo*1

✍ NATHAN, R 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 30 KB